Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?

Diabetes Metab Syndr. 2020 Jul-Aug;14(4):347. doi: 10.1016/j.dsx.2020.04.010. Epub 2020 Apr 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucagon-Like Peptide-1 Receptor
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Symporters*

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose